TITLE

Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma

AUTHOR(S)
Hothersall, E. J.; Chaudhuri, R.; McSharry, C.; Donnelly, I.; Lafferty, J.; McMahon, A. D.; Weir, C. J.; Meiklejohn, J.; Sattar, N.; Mclnnes, I.; Wood, S.; Thomson, N. C.
PUB. DATE
December 2008
SOURCE
Thorax;Dec2008, Vol. 63 Issue 12, p1070
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Statins have anti-inflammatory properties that may be beneficial in the treatment of asthma. A study was undertaken to test the hypothesis that atorvastatin added to inhaled corticosteroids improves lung function and airway inflammation in atopic adults with asthma. Methods: 54 adults with atopic asthma were recruited to a double-blind randomised controlled crossover trial comparing the effect of oral atorvastatin 40 mg daily with that of a matched placebo on asthma control and airway inflammation. Each treatment was administered for 8 weeks separated by a 6-week washout period. The primary outcome was morning peak expiratory flow (PEF). Secondary outcomes included forced expiratory volume in 1 s, asthma control questionnaire score, airway hyper-responsiveness to methacholine, induced sputum cytology and inflammatory biomarkers. Results: At 8 weeks the change in mean morning PEE compared with baseline did not differ substantially between the atorvastatin and placebo treatment periods (mean difference -0.51/mm, 95% Cl -10.6 to 9.6, p = 0.921). Values for other clinical outcomes were similar between the atorvastatin and placebo treatment periods. The absolute sputum macrophage count was reduced after atorvastatin compared with placebo (mean difference -45.0x10[sup4] cells, 95% Cl -80.1 to -9.7, p = 0.029(, as was the sputum fluid leucotriene B4 (mean difference -88.1 pg/mI, 95% Cl -156.4 to -19.9, p = 0.014). Conclusion: The addition of atorvastatin to inhaled corticosteroids results in no short-term improvement in asthma control but reduces sputum macrophage counts in mild to moderate atopic asthma. The change in sputum macrophage count suggests potential areas for investigation of statins in other chronic lung diseases.
ACCESSION #
35783445

 

Related Articles

  • Over-reliance on quick-fix meds in paediatric asthma.  // PharmacoEconomics & Outcomes News;3/10/2007, Issue 523, p8 

    The article discusses research being done on the treatment of asthma with inhaled corticosteroids. It references a study by A. M. Butz et al., published in the December 2006 issue of the journal "Pediatrics." The study found that although most U.S. children with persistent asthma receive some...

  • Statins May Help People with Asthma Breathe Easier.  // Clarendon Enterprise (TX);4/8/2010, Vol. 21 Issue 14, p5 

    The article reports on the efficiency of statin type medication to improve lung function for asthmatic people as revealed in the research of Beth Israel Medical Center in New York.

  • Does Mild Persistent Asthma Require Regular Treatment? Fabbri, Leonardo M. // New England Journal of Medicine;4/14/2005, Vol. 352 Issue 15, p1589 

    Discusses the treatment of mild persistent asthma. Claim that established guidelines require regular treatment of mild persistent asthma with inhaled corticosteroids; Reference to a study which compared treatment methods; Focus of the study on self-management of mild persistent asthma; Benefits...

  • Nível de controle da asma e sua relação com o uso de medicação em asmáticos no Brasil. Marchioro, Josiane; Rodrigues Gazzotti, Mariana; Augusto Nascimento, Oliver; Montealegre, Federico; Fish, James; Roberto Jardim, José // Jornal Brasileiro de Pneumologia;set/out2014, Vol. 40 Issue 5, p487 

    Objective: To assess asthma patients in Brazil in terms of the level of asthma control, compliance with maintenance treatment, and the use of rescue medication. Methods: We used data from a Latin American survey of a total of 400 asthma patients in four Brazilian state capitals, all of whom...

  • In patients with stable persistent asthma, can lower doses of inhaled corticosteroid medication control symptoms and maintain optimal pulmonary function as well as high doses? Jackson, Eric A. // Journal of Family Practice;Jun2000, Vol. 49 Issue 6, p494 

    This article discusses research being done on the effectiveness of low-dose budesonide in long-term asthma control, with reference to a study by A. Foresi, M. C. Morellu and E. Catena, which appeared in the 2000 issue of the "Chest." Patients included in this study have perennial asthma and...

  • Randomized Comparison of Strategies for Reducing Treatment in Mild Persistent Asthma.  // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2027 

    Background: Treatment guidelines recommend the use of inhaled corticosteroids in patients with asthma who have persistent symptoms and the "stepping down" of therapy to the minimum needed to maintain control of asthma. Whether patients with asthma that is well controlled with the use of inhaled...

  • Treatment of Mild Persistent Asthma.  // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2096 

    The article presents a list of references for the online Clinical Decisions Forum on the treatment of mild persistent asthma. Articles listed include "Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial," by K. Malmstrom and colleagues,...

  • General Practitioners' Intentions and Prescribing for Asthma: Using the Theory of Planned Behavior to Explain Guideline Implementation. Rashidian, Arash; Russell, Ian // International Journal of Preventive Medicine;Jan2012, Vol. 3 Issue 1, p17 

    Objectives: Limited studies have demonstrated that the Theory of Planned Behavior (TPB) may be able to help in explaining the variation in physicians' behavior. We selected the management of asthma as the tracer topic because asthma had nationally known clinical guidelines, and the main...

  • Relationship of Mannitol Challenge to Methacholine Challenge and Inflammatory Markers in Persistent Asthmatics Receiving Inhaled Corticosteroids. Anderson, William; Lipworth, Brian // Lung;Oct2012, Vol. 190 Issue 5, p513 

    Background: Mannitol is a novel osmotic indirect bronchial challenge agent used to aid asthma diagnosis and management and is thought to reflect underlying inflammatory processes in asthma. Our objective was to evaluate relationships between mannitol airway hyperresponsiveness (AHR) and other...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics